Meet our team of experts at the NASP Annual Meeting & Expo in Washington, D.C. September 9 – 12, 2019.
EVERSANA BOOTH #914
Tuesday, September 10 7:00 am – 8:00 pm
Wednesday, September 11 6:00 am – 2:30 pm
Disruptive Therapies Call for a Disruptive Business Model
Scientific breakthroughs in regenerative therapies are disrupting the industry at a rapid pace. Is your current infrastructure and strategy ready to support the unique challenges of this new era of medicine?
According to recent study from Health Strategies Insights by EVERSANA, 35%-45% of pipeline drugs are infusions and injectables that require nursing services, patient education, cold chain, new reimbursement measures and sites of care.
Higher Adherence. Better Outcomes.
Imagine an improved patient experience, faster acquisition and ongoing therapy adherence. With EVERSANA, integrating all your patient services and support under one roof you can streamline your operations and achieve better financial outcomes.
At a time when the industry is struggling to reach rates higher than 60%, EVERSANA clients are benchmarking on the high 90% percentile.
Areas of expertise:
• Rare disease, regenerative therapies and digital therapeutics
• Pharmacy distribution in all 50 states
• Patient services with 90th percentile adherence rates
• Reimbursement
Schedule a meeting to learn how our disruptive business model can help you achieve commercial success.